Skip to main content

The Pandemic Crushed the Flu—What Happens When It Returns?

Cases of influenza and other respiratory viruses sank dramatically during the pandemic, with potential implications for both people and pathogens.  

Written byDiana Kwon
| 8 min read
three children outside with winter gear wearing surgical masks

Register for free to listen to this article
Listen with Speechify
0:00
8:00

ABOVE: © ISTOCK.COM, LMGORTHAND

During the annual flu season, many people experience the usual symptoms: a runny nose, sneezing, body aches, and fever. Flu can also be deadly. In the United States alone, influenza viruses cause hundreds of thousands of hospitalizations and tens of thousands of fatalities each year. During the pandemic, however, a drastic change occurred: there was a precipitous drop in infections with influenza and other respiratory viruses—and in some parts of the world, some of these pathogens are nowhere to be found.

“It’s really dramatic how the flu disappeared this year,” says Ellen Foxman, an immunologist at Yale University. At Yale-New Haven Hospital, where Foxman works, there were around 3,000 confirmed flu cases in the first three months of 2020, Foxman tells The Scientist. “This year, from the first of January until now, there’s zero.”

Mask wearing, social distancing, and other restrictions implemented to stave off SARS-CoV-2 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays